Zachary Wallace to Treatment Outcome
This is a "connection" page, showing publications Zachary Wallace has written about Treatment Outcome.
Connection Strength
0.020
-
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Medicine (Baltimore). 2018 Oct; 97(42):e12631.
Score: 0.007
-
Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Semin Arthritis Rheum. 2018 10; 48(2):288-292.
Score: 0.007
-
Large vessel involvement by IgG4-related disease. Medicine (Baltimore). 2016 Jul; 95(28):e3344.
Score: 0.006